CBRE Stock Analysis: CBRE | NYSE
Real Estate Services | NYSE, USA | Market Cap: 38.125m USD | 12M Return: -14.4% | US12504L1098 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 294M
EPS Trend: 97.0%
Qual. Beats: 0
Rev. Trend: 99.6%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
CBRE Group, Inc. is a global commercial real estate services and investment firm headquartered in Dallas, Texas, founded in 1906 and listed on the NYSE since 2004. The company operates across the United States, the United Kingdom, and internationally through four main segments: Advisory Services, Building Operations and Experience, Project Management, and Real Estate Investments.
Its Advisory Services segment covers leasing, capital markets, mortgage and structured financing, property management, valuation, and consulting for office, industrial, and retail properties. The Global Workplace Solutions (formerly Project Management) segment delivers facilities management and project management services under the Turner & Townsend brand, while the Real Estate Investments segment provides investment management through CBRE Investment Management to institutional clients such as pension funds, insurance companies, and sovereign wealth funds, alongside development activities under the Trammell Crow Company brand.
CBREs business model is predominantly fee-based, generating revenue from advisory, brokerage, property management, facilities management, and investment management services rather than from direct ownership of real estate assets, though it does co-invest alongside clients. As a member of the Real Estate sector (GICS Sub Industry: Real Estate Development), it competes with other large global commercial real estate services platforms such as JLL and Cushman & Wakefield.
- Capital Markets revenue pressured by rising interest rates
- Office sector weakness weighs on leasing advisory fees
- Investment Management AUM growth drives recurring fee revenue
| Net Income: 1.30b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -1.17 > 1.0 |
| NWC/Revenue: 3.65% < 20% (prev 3.51%; Δ 0.15% < -1%) |
| CFO/TA 0.04 > 3% & CFO 1.36b > Net Income 1.30b |
| Net Debt (11.6b) to EBITDA (2.98b): 3.88 < 3 |
| Current Ratio: 1.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (297.0m) vs 12m ago -1.96% < -2% |
| Gross Margin: 17.66% > 18% (prev 38.61%; Δ -20.96% > 0.5%) |
| Asset Turnover: 150.1% > 50% (prev 137.6%; Δ 12.47% > 0%) |
| Interest Coverage Ratio: 10.29 > 6 (EBIT TTM 2.02b / Interest Expense TTM 196.0m) |
| A: 0.05 (Total Current Assets 12.9b - Total Current Liabilities 11.3b) / Total Assets 30.5b |
| B: 0.31 (Retained Earnings 9.51b / Total Assets 30.5b) |
| C: 0.07 (EBIT TTM 2.02b / Avg Total Assets 29.1b) |
| D: 0.39 (Book Value of Equity 8.40b / Total Liabilities 21.3b) |
| Altman-Z'' = 2.24 = BBB |
| DSRI: 0.88 (Receivables 9.51b/9.46b, Revenue 43.6b/38.1b) |
| GMI: 2.19 (GM 38.61% / 17.66%) |
| AQI: 1.02 (AQ_t 0.47 / AQ_t-1 0.46) |
| SGI: 1.15 (Revenue 43.6b / 38.1b) |
| TATA: -0.00 (NI 1.30b - CFO 1.36b) / TA 30.5b) |
| Beneish M = -1.93 (Cap -4..+1) = B |
As of October 17, 2026, the stock is trading at USD 133.08 with a total of 2,248,957 shares traded. Over the past week, the price has changed by +1.74%, over one month by -3.95%, over three months by -7.38% and over the past year by -14.37%.
Current recommended Stop Loss: 124.80 (which is 6.2% or 1.9 ATR below the current price).
CBRE has received a consensus analysts rating of 4.46. Therefore, it is recommended to buy CBRE.
- StrongBuy: 7
- Buy: 5
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 179.7 | 35% |
P/E Trailing = 30.3364
P/E Forward = 14.9254
P/S = 0.8719
P/B = 4.804
P/EG = 0.7429
Revenue TTM = 43.6b USD
EBIT TTM = 2.02b USD
EBITDA TTM = 2.98b USD
Long Term Debt = 5.73b USD (from longTermDebt, last quarter)
Short Term Debt = 2.69b USD (from shortTermDebt, last quarter)
Debt = 13.1b USD (from shortLongTermDebtTotal, last quarter) + Leases 2.48b
Net Debt = 11.6b USD (calculated: Debt 13.1b - CCE 1.49b)
Enterprise Value = 49.7b USD (38.1b + Debt 13.1b - CCE 1.49b)
Interest Coverage Ratio = 10.29 (Ebit TTM 2.02b / Interest Expense TTM 196.0m)
EV/FCF = 52.98x (Enterprise Value 49.7b / FCF TTM 938.0m)
FCF Yield = 1.89% (FCF TTM 938.0m / Enterprise Value 49.7b)
FCF Margin = 2.15% (FCF TTM 938.0m / Revenue TTM 43.6b)
Net Margin = 2.98% (Net Income TTM 1.30b / Revenue TTM 43.6b)
Gross Margin = 17.66% ((Revenue TTM 43.6b - Cost of Revenue TTM 35.9b) / Revenue TTM)
Gross Margin QoQ = 18.58% (prev 17.59%)
Tobins Q-Ratio = 1.63 (Enterprise Value 49.7b / Total Assets 30.5b)
Interest Expense / Debt = 1.50% (Interest Expense 196.0m / Debt 13.1b)
Taxrate = 21.15% (385.0m / 1.82b)
NOPAT = 1.59b (EBIT 2.02b * (1 - 21.15%))
Current Ratio = 1.14 (Total Current Assets 12.9b / Total Current Liabilities 11.3b)
Debt / Equity = 1.56 (Debt 13.1b / totalStockholderEquity, last quarter 8.40b)
Debt / EBITDA = 3.88 (Net Debt 11.6b / EBITDA 2.98b)
Debt / FCF = 12.34 (Net Debt 11.6b / FCF TTM 938.0m)
Total Stockholder Equity = 8.58b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.47% (Net Income 1.30b / Total Assets 30.5b)
RoE = 15.16% (Net Income TTM 1.30b / Total Stockholder Equity 8.58b)
RoCE = 14.08% (EBIT 2.02b / Capital Employed (Equity 8.58b + L.T.Debt 5.73b))
RoIC = 7.81% (NOPAT 1.59b / Invested Capital 20.4b)
WACC = 6.60% (E(38.1b)/V(51.2b) * Re(8.46%) + D(13.1b)/V(51.2b) * Rd(1.50%) * (1-Tc(0.21)))
Discount Rate = 8.46% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.11 | Cagr: -1.68%
[DCF] Terminal Value 73.10% ; FCFF base≈1.03b ; Y1≈906.1m ; Y5≈732.1m
[DCF] Fair Price = 0.62 (EV 11.8b - Net Debt 11.6b = Equity 178.3m / Shares 289.6m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 96.99 | EPS CAGR: 32.70% | SUE: 0.66 | # QB: 0
Revenue Correlation: 99.64 | Revenue CAGR: 13.32% | SUE: -0.32 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.96 | Chg30d=+0.15% | Revisions=+25% | Analysts=11
EPS current Year (2026-12-31): EPS=7.82 | Chg30d=+0.04% | Revisions=+64% | GrowthEPS=+22.5% | GrowthRev=+16.0%
EPS next Year (2027-12-31): EPS=9.04 | Chg30d=-0.66% | Revisions=-25% | GrowthEPS=+15.6% | GrowthRev=+11.1%
[Analyst] Revisions Ratio: +56% (up=11, down=2)